1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Neuropathy Global Clinical Trials Review, H2, 2014

Neuropathy Global Clinical Trials Review, H2, 2014

  • July 2014
  • -
  • GlobalData
  • -
  • 131 pages

Neuropathy Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuropathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neuropathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Neuropathy Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Neuropathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Neuropathy to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Neuropathy to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Neuropathy 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Neuropathy Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Sanofi 37
Clinical Trial Overview of Sanofi 37
NeurogesX, Inc. 38
Clinical Trial Overview of NeurogesX, Inc. 38
GW Pharmaceuticals plc 39
Clinical Trial Overview of GW Pharmaceuticals plc 39
Sumitomo Chemical Company, Limited 40
Clinical Trial Overview of Sumitomo Chemical Company, Limited 40
CSL Limited 41
Clinical Trial Overview of CSL Limited 41
Grunenthal GmbH 42
Clinical Trial Overview of Grunenthal GmbH 42
Eli Lilly and Company 43
Clinical Trial Overview of Eli Lilly and Company 43
Baxter International Inc. 44
Clinical Trial Overview of Baxter International Inc. 44
Astellas Pharma Inc. 45
Clinical Trial Overview of Astellas Pharma Inc. 45
Clinical Trial Overview of Top Institutes / Government 46
University of Texas M. D. Anderson Cancer Center 46
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 46
National Taiwan University Hospital 47
Clinical Trial Overview of National Taiwan University Hospital 47
U.S. Department of Veterans Affairs 48
Clinical Trial Overview of U.S. Department of Veterans Affairs 48
Odense University Hospital 49
Clinical Trial Overview of Odense University Hospital 49
Columbia University 50
Clinical Trial Overview of Columbia University 50
The National Institute of Allergy and Infectious Diseases 51
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 51
Washington University School of Medicine 52
Clinical Trial Overview of Washington University School of Medicine 52
National Center for Research Resources 53
Clinical Trial Overview of National Center for Research Resources 53
Rigshospitalet 54
Clinical Trial Overview of Rigshospitalet 54
Oregon Health and Science University 55
Clinical Trial Overview of Oregon Health and Science University 55
Five Key Clinical Profiles 56
Appendix 129
Abbreviations 129
Definitions 129
Research Methodology 130
Secondary Research 130
About GlobalData 131
Contact Us 131
Disclaimer 131
Source 131

List of Tables
Neuropathy Therapeutics, Global, Clinical Trials by Region, 2014* 7
Neuropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Neuropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Neuropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Neuropathy Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Neuropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Neuropathy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Neuropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Neuropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Neuropathy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Neuropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Neuropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Neuropathy Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Neuropathy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Neuropathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Neuropathy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Neuropathy Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Neuropathy Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Neuropathy Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Neuropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 30
Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 33
Neuropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 35
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 37
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by NeurogesX, Inc., 2014* 38
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2014* 39
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sumitomo Chemical Company, Limited, 2014* 40
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2014* 41
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Grunenthal GmbH, 2014* 42
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 43
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014* 44
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 45
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2014* 46
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 47
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 48
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2014* 49
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2014* 50
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 51
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 52
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 53
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014* 54
Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2014* 55

List of Figures
Neuropathy Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Neuropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Neuropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Neuropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Neuropathy Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Neuropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Neuropathy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Neuropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Neuropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Neuropathy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Neuropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Neuropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Neuropathy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Neuropathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Neuropathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Neuropathy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Neuropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 30
Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Neuropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
GlobalData Methodology 130

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Global Clinical Trial Management System Growth, Trends and Forecasts (2017 - 2022)

Global Clinical Trial Management System Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The Global market for Clinical Trial Management System is expected to reach $2 billion by the end of 2020 growing at a CAGR of around 12.5% from 2014 to 2021. Clinical Trial Management System is a system ...

Global Clinical Trials Market Growth, Trends and Forecasts (2017 - 2022)

Global Clinical Trials Market Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The global clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.